THE PANEL


STEPHEN LOWES SOLUTIONS


SENIOR DIRECTOR – SCIENTIFIC, BIOANALYSIS AND ADME Q2


Prior to joining Q2 Solutions in 2011, Dr. Lowes


was an executive management scientific leader of Advion BioServices. Dr. Lowes started his industrial career at VG Biotech in the UK that became the LC/MS instrument entity of Waters Corporation. In 1995 Dr. Lowes joined the CRO group that became Advion and focused his career on regulated bioanalysis with particular emphasis on LC/MS. He has remained very connected on


10


regulatory developments in bioanalysis and is a founding member of the Global Bioanalysis Consortium (GBC) and a past-chair of the AAPS Bioanalytical Focus Group. At Q2


Solutions, Dr. Lowes leads


the scientific disciplines around LC/MS bioanalysis for both small molecule and biomolecule applications including biomarker assays. Dr. Lowes has over 40 peer reviewed publications on bioanalysis and is a frequent speaker at national and international conferences.


Dr. Lowes earned his Ph.D. in analytical chemistry from the Open University, United Kingdom.


SCOTT SUMMERFIELD WW HEAD OF BIOANALYSIS GLAXOSMITHKLINE


Having studied for a PhD and post doctoral fellowship in prote omics Scott moved into the field of regulated Bioanalysis in 1997 when joining SmithKline Beecham. In 2001 Scott moved to Neuroscience Drug Discovery to lead a bioanalytical team supporting PK, in vitro DMPK and metabolite id work. In 2009 he returned to the regulated bioanalytical group, initially as a Section Leader and subsequently as Site Head and currently as WW Head of Bioanalysis at GSK. Scott has experience of small and molecule bioanalysis as well as leading both bioanalytical and discovery and development project teams across GSK.


www.bioanalysis-zone.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18